Descending bulbospinal serotonergic pain-suppressing pathways

Where it participates (unsigned role)

1. In thermal, mechanical and chemical pain tests the specific cannabinoid receptor 1 antagonist AM-251 abolished the analgesic action of acetaminophen, which was also lost in cannabinoid receptor 1 knockout mice, yet acetaminophen was shown unable to bind to those receptors demonstrating an indirect involvement, inhibition of fatty acid amide hydrolase suppressed the effect, and the antinociceptive activity of a cannabinoid receptor 1 agonist was itself inhibited by lesion of bulbospinal serotonergic pathways and by spinal 5-HT receptor antagonists, leading the authors to propose a sequence of metabolism to AM404, indirect cannabinoid receptor involvement, reinforcement of serotonergic bulbospinal pathways and action at spinal serotonergic receptors.

   Human cannabinoid receptor 1 / CB1 / CNR1 → Antinociception in thermal, mechanical and chemical pain tests source_derived_draftungraded
   Experimental context and source evidence

   evidence_span

   {"source_cache": "artifacts/paracetamol-research/18485596.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9bd927cbceffd6cf3a23e34bb0a6ce1584f989173a383745a97b82222f89798f", "start_char": 0, "end_char": 1545, "text_sha256": "9bd927cbceffd6cf3a23e34bb0a6ce1584f989173a383745a97b82222f89798f"}

   experimental_model

   Thermal, mechanical and chemical pain tests in cannabinoid receptor 1 knockout mice with receptor binding and pathway lesions

   exposure

   Acetaminophen with AM-251, cannabinoid receptor 1 deletion, fatty acid amide hydrolase inhibition and serotonergic pathway lesion

   limitations

   The binding experiment is what makes the receptor involvement indirect rather than direct, which is the substantive point. The proposed sequence is the authors’ synthesis.

   nutrient_topic

   Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol

   organism

   Mouse

   plain_language

   The drug needs the cannabinoid receptor but never touches it, which is what a metabolite doing the work looks like.

   primary_references

   [apap-p18485596] Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. (2008). https://pubmed.ncbi.nlm.nih.gov/18485596/ DOI: 10.1016/j.pain.2008.03.030

   tissue_or_cell_type

   Brain and spinal cord

   Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22) · lines 337–348

   AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Thermal, mechanical and chemical pain tests in cannabinoid receptor 1 knockout mice with receptor binding and pathway lesions · source_derived_draft · unverified_draft

   ### apap-cb1-needed-but-not-bound In thermal, mechanical and chemical pain tests the specific cannabinoid receptor 1 antagonist AM-251 abolished the analgesic action of acetaminophen, which was also lost in cannabinoid receptor 1 knockout mice, yet acetaminophen was shown unable to bind to those receptors demonstrating an indirect involvement, inhibition of fatty acid amide hydrolase suppressed the effect, and the antinociceptive activity of a cannabinoid receptor 1 agonist was itself inhibited by lesion of bulbospinal serotonergic pathways and by spinal 5-HT receptor antagonists, leading the authors to propose a sequence of metabolism to AM404, indirect cannabinoid receptor involvement, reinforcement of serotonergic bulbospinal pathways and action at spinal serotonergic receptors. Condition category: normal nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: The drug needs the cannabinoid receptor but never touches it, which is what a metabolite doing the work looks like. organism: Mouse tissue_or_cell_type: Brain and spinal cord experimental_model: Thermal, mechanical and chemical pain tests in cannabinoid receptor 1 knockout mice with receptor binding and pathway lesions limitations: The binding experiment is what makes the receptor involvement indirect rather than direct, which is the substantive point. The proposed sequence is the authors’ synthesis. exposure: Acetaminophen with AM-251, cannabinoid receptor 1 deletion, fatty acid amide hydrolase inhibition and serotonergic pathway lesion evidence_span: {"source_cache": "artifacts/paracetamol-research/18485596.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9bd927cbceffd6cf3a23e34bb0a6ce1584f989173a383745a97b82222f89798f", "start_char": 0, "end_char": 1545, "text_sha256": "9bd927cbceffd6cf3a23e34bb0a6ce1584f989173a383745a97b82222f89798f"} [apap-p18485596] Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. (2008). https://pubmed.ncbi.nlm.nih.gov/18485596/ DOI: 10.1016/j.pain.2008.03.030

   Complete structured claim and evidence

2. Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine led to dose-dependent formation of AM404 and of arvanil and olvanil respectively in the mouse brain, the order of potency of these lipid metabolites as TRPV1 activators being arvanil equal to olvanil much greater than AM404, both parent amines displayed antinociceptive activity in rodent pain tests, formation of these metabolites and the antinociceptive effects were substantially reduced or disappeared in fatty acid amide hydrolase null mice, activity was lost in TRPV1 null mice, intracerebroventricular capsazepine eliminated the effects, and in the rat, inhibition of fatty acid amide hydrolase, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors and chemical deletion of bulbospinal serotonergic pathways all prevented the action, giving a pharmacological profile identical to that previously reported for paracetamol.

   4-aminophenol → AM404 / N-arachidonoylphenolamine source_derived_draftungraded
   Experimental context and source evidence

   evidence_span

   {"source_cache": "artifacts/paracetamol-research/23940628.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44", "start_char": 0, "end_char": 2208, "text_sha256": "cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44"}

   experimental_model

   Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade

   exposure

   Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine, with fatty acid amide hydrolase, TRPV1, cannabinoid and serotonergic manipulations

   limitations

   The broadest test of the route: it reconstructs the whole chain from metabolite formation to descending pathway, and shows the profile of the metabolite matches that of the parent drug.

   nutrient_topic

   Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol

   organism

   Mouse and rat

   plain_language

   Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling.

   primary_references

   [apap-p23940628] Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. (2013). https://pubmed.ncbi.nlm.nih.gov/23940628/ DOI: 10.1371/journal.pone.0070690

   tissue_or_cell_type

   Brain and spinal cord

   Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22) · lines 324–335

   AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade · source_derived_draft · unverified_draft

   ### apap-the-whole-chain Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine led to dose-dependent formation of AM404 and of arvanil and olvanil respectively in the mouse brain, the order of potency of these lipid metabolites as TRPV1 activators being arvanil equal to olvanil much greater than AM404, both parent amines displayed antinociceptive activity in rodent pain tests, formation of these metabolites and the antinociceptive effects were substantially reduced or disappeared in fatty acid amide hydrolase null mice, activity was lost in TRPV1 null mice, intracerebroventricular capsazepine eliminated the effects, and in the rat, inhibition of fatty acid amide hydrolase, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors and chemical deletion of bulbospinal serotonergic pathways all prevented the action, giving a pharmacological profile identical to that previously reported for paracetamol. Condition category: normal nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling. organism: Mouse and rat tissue_or_cell_type: Brain and spinal cord experimental_model: Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade limitations: The broadest test of the route: it reconstructs the whole chain from metabolite formation to descending pathway, and shows the profile of the metabolite matches that of the parent drug. exposure: Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine, with fatty acid amide hydrolase, TRPV1, cannabinoid and serotonergic manipulations evidence_span: {"source_cache": "artifacts/paracetamol-research/23940628.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44", "start_char": 0, "end_char": 2208, "text_sha256": "cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44"} [apap-p23940628] Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. (2013). https://pubmed.ncbi.nlm.nih.gov/23940628/ DOI: 10.1371/journal.pone.0070690

   Complete structured claim and evidence